Studies have shown that the intracerebroventricular infusion of OKA (70 ng/day) in rats results in the manifestation of Alzheimer’s disease-related pathologies, namely, tau hyperphosphorylation, apoptosis, and the cortical accumulation of nonfibrillar Aβ [200]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.